SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 240 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,091,303 | -34.2% | 39,583 | -28.3% | 0.00% | -33.3% |
| Q2 2023 | $1,658,680 | -50.2% | 55,179 | -39.9% | 0.00% | -50.0% |
| Q1 2023 | $3,328,450 | +52.3% | 91,870 | +50.0% | 0.01% | +50.0% |
| Q4 2022 | $2,185,108 | +570.3% | 61,259 | +535.1% | 0.00% | +300.0% |
| Q3 2022 | $326,000 | +359.2% | 9,646 | +289.6% | 0.00% | – |
| Q2 2022 | $71,000 | -96.5% | 2,476 | -96.0% | 0.00% | -100.0% |
| Q1 2022 | $2,003,000 | +4.9% | 61,989 | -5.4% | 0.00% | +50.0% |
| Q4 2021 | $1,909,000 | – | 65,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 699,432 | $35,216,000 | 4.25% |
| Provident Investment Management, Inc. | 590,269 | $29,720,000 | 4.23% |
| CAPITAL MANAGEMENT CORP /VA | 225,232 | $11,340,000 | 2.90% |
| FALCON POINT CAPITAL, LLC | 188,341 | $9,483,000 | 2.04% |
| Ranger Investment Management | 600,464 | $30,233,000 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 471,260 | $23,728,000 | 1.96% |
| KOPP INVESTMENT ADVISORS LLC | 41,700 | $2,100,000 | 1.77% |
| SHAKER INVESTMENTS LLC/OH | 49,617 | $2,498,000 | 1.54% |
| Bruce & Co., Inc. | 148,058 | $7,454,000 | 1.44% |
| Bridge City Capital, LLC | 45,843 | $2,308,000 | 1.43% |